Today, science allows us to examine a person's genetic makeup and use their information to predict risk for some cancers, give a diagnosis of cancer and determine how a patient will respond to treatment; allowing for targeted therapies. This breakthrough field, called molecular oncology, has evolved rapidly. To ensure Ontarians have access to these services and the health system can meet demand, the Molecular Oncology Task Force, sponsored by Cancer Care Ontario (CCO), released its report and recommendations today.
